Technology
Health
Biotechnology

Solid Biosciences

$9.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (1.29%) As of 1:57 PM EDT today
+$0.12 (1.29%) Today

Why Robinhood?

You can buy or sell SLDB and other stocks, options, ETFs, and crypto commission-free!

About SLDB

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. Read More The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.

Employees
111
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
427.81M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
927.92K
High Today
$9.54
Low Today
$8.91
Open Price
$9.21
Volume
516.80K
52 Week High
$54.54
52 Week Low
$4.32

Collections

Technology
Health
Biotechnology
Gene Therapies
2018 IPO
US
North America

SLDB Earnings

-$0.85
-$0.74
-$0.62
-$0.51
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.79 per share
Actual
-$0.76 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.